BioScience Laboratories Announces Testing Capabilities for Clostridium Difficile
BioScience Laboratories announces the capability of product efficacy testing versus Clostridium difficile spores.

BOZEMAN, MT, July 16, 2011 /24-7PressRelease/ -- BioScience Laboratories announces the capability of product efficacy testing versus Clostridium difficile spores. In response to the recent hospital infection related fatalities caused by Clostridium difficile, BioScience Laboratories reminds disinfectant manufacturers that efficacy versus Clostridium difficile spores can be determined through in-vitro testing. In spore form, Clostridium difficile can survive heat and drying, and is resistant to many legacy disinfectants. These spores can live up to five months on surfaces and in the environment. Efficacy testing performed at BioScience Laboratories can show that new disinfectant product formulations are effective versus Clostridium difficile spores.

For additional information, contact:
John Dyba
BioScience Laboratories, Inc.
1-877-858-2754
FAX 406-586-7930
jdyba@biosciencelabs.com
www.biosciencelabs.com

Press Release Contact Information:

John Dyba
BioScience Laboratories
Senior Account Executive
300 N Willson, Suite 1
Bozeman, MT
USA 59715
Voice: 406-587-5735
Website: Visit Our Website